Page 19 - Alkermes News Today

Operating and Growing Responsibly at Alkermes

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the Registration Statement on Form 10, as amended (Form 10), filed by Mural Oncology plc...

31.10.2023 - NORTHAMPTON, MA / ACCESSWIRE / October 31, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportStakeholder EngagementWe recognize that our stakeholders - including employees, healthcare providers, patients, ...

Alkermes plc (Nasdaq: ALKS) today announced that the Registration Statement on Form 10, as amended (Form 10), filed by Mural Oncology plc (Mural Oncology) was declared effective by the U.S. Securities and Exchange Commission (SEC). This Form 10 describes Alkermes' planned separation of its oncology business into Mural Oncology, which, upon completion of the separation, will be a new, independent, publicly traded company.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 30, 2023--

Evercore ISI upgraded shares of Alkermes (NASDAQ:ALKS – Free Report) from an in-line rating to an outperform rating in a report released on Tuesday morning, MarketBeat.com reports. ALKS has been the topic of a number of other reports. StockNews.com downgraded shares of Alkermes from a strong-buy rating to a buy rating in a report on […]

Evercore ISI upgraded shares of Alkermes (NASDAQ:ALKS – Free Report) from an in-line rating to an outperform rating in a research note issued to investors on Tuesday, MarketBeat reports. Other equities analysts have also issued reports about the stock. StockNews.com lowered shares of Alkermes from a strong-buy rating to a buy rating in a report […]

Hussman Strategic Advisors Inc. lowered its stake in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 20.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,400 shares of the company’s stock after selling 3,100 shares during the period. Hussman Strategic Advisors Inc.’s holdings in […]

Operator: Greetings. And welcome to the Alkermes Third Quarter 2023 Financial Results Conference Call. My name is Donna and I’ll be your operator for today’s call.

Stock Analysts’ upgrades for Wednesday, October 25th: Alkermes (NASDAQ:ALKS) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Banc of California (NYSE:BANC) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Atlanta Braves (NASDAQ:BATRK) was upgraded by analysts at StockNews.com from a sell rating to […]